Ireland authorized Aurora’s cannabidiol solution below its Healthcare Cannabis Access Plan (MCAP) for the remedy of spasticity connected to several sclerosis, chemotherapy-induced nausea and vomiting and remedy-resistant epilepsy. It is 1 of only two products to date to achieve such authorization below the system.
Aurora’s Chief Solution Officer, Dr. Shane Morris, stated he expects the firm will be in a position to provide treatment options for a lot more healthcare circumstances in the future.
“We appear forward to a lot more of Aurora’s higher-excellent medicines getting authorized, so that a lot more individuals can advantage from the MCAP in Ireland,” he stated in a news release. “We will continue to operate closely with all parties and state agencies to facilitate additional availability.”
Ireland’s Minister for Well being, Simon Harris, signed MCAP into law in June. It aims to facilitate access to cannabis-primarily based healthcare solutions and is scheduled to run for five years